OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 2 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $570,000 | +40.7% | 29,992 | 0.0% | 0.02% | +41.2% |
| Q4 2018 | $405,000 | +21.6% | 29,992 | 0.0% | 0.02% | +41.7% |
| Q3 2018 | $333,000 | +160.2% | 29,992 | +15.4% | 0.01% | +200.0% |
| Q4 2016 | $128,000 | -0.8% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $129,000 | +40.2% | 26,000 | +44.4% | 0.00% | +33.3% |
| Q2 2016 | $92,000 | -10.7% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $103,000 | -44.9% | 18,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $187,000 | -15.8% | 18,000 | +50.0% | 0.01% | -33.3% |
| Q3 2015 | $222,000 | +3.7% | 12,000 | +9.1% | 0.01% | +12.5% |
| Q2 2015 | $214,000 | +51.8% | 11,000 | +37.5% | 0.01% | +60.0% |
| Q1 2015 | $141,000 | +46.9% | 8,000 | +33.3% | 0.01% | +25.0% |
| Q4 2014 | $96,000 | +52.4% | 6,000 | +20.0% | 0.00% | +33.3% |
| Q3 2014 | $63,000 | -19.2% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $78,000 | +18.2% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $66,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|